Shofu (7979) - Marked Recovery QoQ and in Line with Expectations
Demonstrating dependable growth – Q1-3 FY3/2024 results were in line with company guidance, driven by a combination of demand recovery in the Americas
328 Views
Shofu (7979 JP) - Competitive Advantage Driving Predictability in Earnings Growth
Q1-2 FY3/2024 results were in line with upwardly-revised company guidance, with gross margins reaching 60.4% and a record-high quarterly level of...
335 Views
Shofu (7979 JP) - Domestic Star Franchise Aiming for Global Center Stage
From a niche player to a global high-flyer – Shofu is a domestic market leader in developing and manufacturing dental materials and equipment.
314 Views
Opdivo Singled Out in Government Rule Change
The suggestion of government orchestration against Ono’s immunotherapy treatment Opdivo (nivolumab) has moved a stage further with a report in the...
5.8k Views